Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatmentsLorenzo Canova, Massimo Iavarone, Eleonora Alimenti, et al.
Plos One|October 25, 2013
PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinomaLuca Valenti, Benedetta Maria Motta, Giorgio Soardo, et al.
Liver Cancer|June 11, 2025
The Concept of "Converse Therapeutic Hierarchy" for Patients with Hepatocellular CarcinomaAlessandro Vitale, Giuseppe Cabibbo, Lorenza Rimassa, et al.
Transplantation|September 14, 2019
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver TransplantationFederica Invernizzi, Massimo Iavarone, Claudio Zavaglia, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2021
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agentsElisabetta Degasperi, Riccardo Perbellini, Roberta D'Ambrosio, et al.
Annals of Hepatology|January 10, 2018
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationMarco Biolato, Giulia Gallusi, Massimo Iavarone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of DeathGiuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia, et al.
Journal of Hepatology|November 15, 2017
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodulesEleonora Terzi, Massimo Iavarone, Maurizio Pompili, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|February 24, 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Jae Yeon Seok, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatmentsLorenzo Canova, Massimo Iavarone, Eleonora Alimenti, et al.
Plos One|October 25, 2013
PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinomaLuca Valenti, Benedetta Maria Motta, Giorgio Soardo, et al.
Liver Cancer|June 11, 2025
The Concept of "Converse Therapeutic Hierarchy" for Patients with Hepatocellular CarcinomaAlessandro Vitale, Giuseppe Cabibbo, Lorenza Rimassa, et al.
Transplantation|September 14, 2019
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver TransplantationFederica Invernizzi, Massimo Iavarone, Claudio Zavaglia, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2021
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agentsElisabetta Degasperi, Riccardo Perbellini, Roberta D'Ambrosio, et al.
Annals of Hepatology|January 10, 2018
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationMarco Biolato, Giulia Gallusi, Massimo Iavarone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of DeathGiuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia, et al.
Journal of Hepatology|November 15, 2017
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodulesEleonora Terzi, Massimo Iavarone, Maurizio Pompili, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|February 24, 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Jae Yeon Seok, et al.
Pageof 15